Literature DB >> 26538455

Mass immunization with inactivated polio vaccine in conflict zones--Experience from Borno and Yobe States, North-Eastern Nigeria.

Faisal M Shuaibu1, Gerida Birukila2, Samuel Usman3, Ado Mohammed4, Michael Galway5, Melissa Corkum4,6, Eunice Damisa1, Pascal Mkanda5,7, Frank Mahoney6,8, Gatei Wa Nganda8, John Vertefeuille8, Anna Chavez5,7, Sule Meleh7,9, Richard Banda5,7, Almai Some7,9, Hyelni Mshelia7,9, Al-Umra Umar4,6, Ogu Enemaku4,6, Andrew Etsano1.   

Abstract

The use of Inactivated Polio Vaccine (IPV) in routine immunization to replace Oral Polio Vaccine (OPV) is crucial in eradicating polio. In June 2014, Nigeria launched an IPV campaign in the conflict-affected states of Borno and Yobe, the largest ever implemented in Africa. We present the initiatives and lessons learned. The 8-day event involved two parallel campaigns. OPV target age was 0-59 months, while IPV targeted all children aged 14 weeks to 59 months. The Borno state primary health care agency set up temporary health camps for the exercise and treated minor ailments for all. The target population for the OPV campaign was 685,674 children in Borno and 113,774 in Yobe. The IPV target population for Borno was 608,964 and for Yobe 111,570. OPV coverage was 105.1 per cent for Borno and 103.3 per cent for Yobe. IPV coverage was 102.9 per cent for Borno and 99.1 per cent for Yobe. (Where we describe coverage as greater than 100 per cent, this reflects original underestimates of the target populations.) A successful campaign and IPV immunization is viable in conflict areas.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26538455     DOI: 10.1057/jphp.2015.34

Source DB:  PubMed          Journal:  J Public Health Policy        ISSN: 0197-5897            Impact factor:   2.222


  14 in total

1.  Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.

Authors:  T M Herremans; J H Reimerink; A M Buisman; T G Kimman; M P Koopmans
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

2.  Effectiveness of Salk vaccine. Analysis of virologically confirmed cases of paralytic and nonparalytic poliomyelitis.

Authors:  J L MELNICK; M BENYESH-MELNICK; R PENA; M YOW
Journal:  JAMA       Date:  1961-04-01       Impact factor: 56.272

3.  Tracking progress towards global polio eradication, 2011 – 2012.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2013-04-12

4.  Antigen content of inactivated poliovirus vaccine for use in a one- or two-dose regimen.

Authors:  J Salk; P Stoeckel; A L van Wezel; K Lapinleimu; G van Steenis
Journal:  Ann Clin Res       Date:  1982-12

5.  Perspectives on polio and immunization in Northern Nigeria.

Authors:  Elisha Renne
Journal:  Soc Sci Med       Date:  2006-06-12       Impact factor: 4.634

6.  Eradication of indigenous poliomyelitis in Canada: impact of immunization strategies.

Authors:  P V Varughese; A O Carter; S E Acres; J Furesz
Journal:  Can J Public Health       Date:  1989 Sep-Oct

7.  Polio eradication. Efficacy of inactivated poliovirus vaccine in India.

Authors:  Hamid Jafari; Jagadish M Deshpande; Roland W Sutter; Sunil Bahl; Harish Verma; Mohammad Ahmad; Abhishek Kunwar; Rakesh Vishwakarma; Ashutosh Agarwal; Shilpi Jain; Concepcion Estivariz; Raman Sethi; Natalie A Molodecky; Nicholas C Grassly; Mark A Pallansch; Arani Chatterjee; R Bruce Aylward
Journal:  Science       Date:  2014-08-22       Impact factor: 47.728

8.  Determinants of health disparities: the perennial struggle against polio in Nigeria.

Authors:  Nosayaba Osazuwa-Peters
Journal:  Int J Prev Med       Date:  2011-07

9.  Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial.

Authors:  Jacob John; Sidhartha Giri; Arun S Karthikeyan; Miren Iturriza-Gomara; Jayaprakash Muliyil; Asha Abraham; Nicholas C Grassly; Gagandeep Kang
Journal:  Lancet       Date:  2014-07-10       Impact factor: 79.321

10.  Combined use of inactivated and oral poliovirus vaccines in refugee camps and surrounding communities - Kenya, December 2013.

Authors:  Mohamed A Sheikh; Frederick Makokha; Abdullahi M Hussein; Gedi Mohamed; Ondrej Mach; Kabir Humayun; Samuel Okiror; Leila Abrar; Orkhan Nasibov; John Burton; Ahmed Unshur; Kathleen Wannemuehler; Concepcion F Estivariz
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-03-21       Impact factor: 17.586

View more
  9 in total

1.  Approaches to Vaccination Among Populations in Areas of Conflict.

Authors:  Chimeremma Nnadi; Andrew Etsano; Belinda Uba; Chima Ohuabunwo; Musa Melton; Gatei Wa Nganda; Lisa Esapa; Omotayo Bolu; Frank Mahoney; John Vertefeuille; Eric Wiesen; Elias Durry
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

2.  Community engagement and integrated health and polio immunisation campaigns in conflict-affected areas of Pakistan: a cluster randomised controlled trial.

Authors:  Muhammad Atif Habib; Sajid Soofi; Simon Cousens; Saeed Anwar; Najib Ul Haque; Imran Ahmed; Noshad Ali; Rehman Tahir; Zulfiqar A Bhutta
Journal:  Lancet Glob Health       Date:  2017-06       Impact factor: 26.763

3.  Estimated Effect of Inactivated Poliovirus Vaccine Campaigns, Nigeria and Pakistan, January 2014-April 2016.

Authors:  George Shirreff; Mufti Zubair Wadood; Rui Gama Vaz; Roland W Sutter; Nicholas C Grassly
Journal:  Emerg Infect Dis       Date:  2017-02-15       Impact factor: 6.883

4.  Delivering infectious disease interventions to women and children in conflict settings: a systematic reviefw.

Authors:  Sarah Meteke; Marianne Stefopulos; Daina Als; Michelle Gaffey; Mahdis Kamali; Fahad J Siddiqui; Mariella Munyuzangabo; Reena P Jain; Shailja Shah; Amruta Radhakrishnan; Anushka Ataullahjan; Zulfiqar A Bhutta
Journal:  BMJ Glob Health       Date:  2020-04

5.  Effect of intensive training in improving older women's knowledge and support for infant vaccination in Nigerian urban slums: a before-and-after intervention study.

Authors:  Folusho Mubowale Balogun; Olayinka Samson Bamidele; Eniola Adetola Bamgboye
Journal:  BMC Public Health       Date:  2021-02-02       Impact factor: 3.295

Review 6.  Zero- or missed-dose children in Nigeria: Contributing factors and interventions to overcome immunization service delivery challenges.

Authors:  Kurayi Mahachi; Joss Kessels; Kofi Boateng; Anne Eudes Jean Baptiste; Pamela Mitula; Ebru Ekeman; Laura Nic Lochlainn; Alexander Rosewell; Samir V Sodha; Bernadette Abela-Ridder; Albis Francesco Gabrielli
Journal:  Vaccine       Date:  2022-08-13       Impact factor: 4.169

7.  Costs and Benefits of Including Inactivated in Addition to Oral Poliovirus Vaccine in Outbreak Response After Cessation of Oral Poliovirus Vaccine Use.

Authors:  Radboud J Duintjer Tebbens; Kimberly M Thompson
Journal:  MDM Policy Pract       Date:  2017-03-01

8.  The Impact of Conflict on Immunisation Coverage in 16 Countries.

Authors:  John Grundy; Beverley-Ann Biggs
Journal:  Int J Health Policy Manag       Date:  2019-04-01

9.  The Critical Role and Evaluation of Community Mobilizers in Polio Eradication in Remote Settings in Africa and Asia.

Authors:  Judy Lewis; Karen LeBan; Roma Solomon; Filimona Bisrat; Samuel Usman; Ahmed Arale
Journal:  Glob Health Sci Pract       Date:  2020-09-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.